US at a glance
- Population
- 341.8 million 2025
- Life expectancy at birth
- 78.9 years, 2024
- People aged 65 and over
- 18.4 % of people, 2025
- Health spending per person
- 13,473 US$ per person, 2023
- Doctors
- 3.68 per 1,000 people, 2022
US Digital PCR Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$405.7 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $288.8 Mn | — | — |
| 2025 (base) | $316.5 Mn | +$27.7 Mn | — |
| 2026 (forecast) | $346.9 Mn | +$30.4 Mn | +9.6% |
| 2027 (forecast) | $380.2 Mn | +$33.3 Mn | +20.1% |
| 2028 (forecast) | $416.7 Mn | +$36.5 Mn | +31.7% |
| 2029 (forecast) | $456.7 Mn | +$40.0 Mn | +44.3% |
| 2030 (forecast) | $500.6 Mn | +$43.8 Mn | +58.1% |
| 2031 (forecast) | $548.6 Mn | +$48.1 Mn | +73.3% |
| 2032 (forecast) | $601.3 Mn | +$52.7 Mn | +90% |
| 2033 (forecast) | $659.0 Mn | +$57.7 Mn | +108.2% |
| 2034 (forecast) | $722.3 Mn | +$63.3 Mn | +128.2% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
Digital PCR counts single DNA molecules very precisely, used for cancer monitoring, gene therapy testing and infection detection.
Key segments of the digital PCR market include product (Instruments, Reagents and Software) and application (Oncology, Infectious Disease and Gene Therapy QC).
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the digital PCR market.
Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the digital PCR market room to grow, especially in emerging markets.
Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the digital PCR market.
The digital PCR market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how digital PCR products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.
What doctors and scientists are doing in Digital PCR right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.
[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
From our blog
US · 2 shared keywords
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
Pharmaceuticals · US
Digital Health · US
Healthcare Services · US
Healthcare Services · US
Digital Health · US
Healthcare Services · US